Navigation Links
Medifast Receives Notice Regarding NYSE Listing
Date:12/26/2007

OWINGS MILLS, Md., Dec. 26 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) announced today that it has been notified by the New York Stock Exchange (the "NYSE") that it is not in compliance with the NYSE's continued listing standards. Medifast, Inc. is considered below criteria by the NYSE because over a consecutive 30-day trading period its total market capitalization was less than $75 million and the Company's most recently reported shareholders' equity was below $75 million. Under applicable NYSE procedures, the Company has 45 days from the receipt of the notice to submit a plan to the NYSE to demonstrate its ability to achieve compliance with the continued listing standards within 18 months. The Company plans to submit a plan that will demonstrate compliance with the listing standards within the required time frame.

About Medifast: (http://www.choosemedifast.com)

Medifast has been helping people lose weight and achieve better health for 25 years. Its meal replacement foods have been proven effective in multiple clinical studies, recommended by over 15,000 physicians and used by more than 1 million customers. Medifast offers its customers world-class customer service and nutrition support.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's o
'/>"/>

SOURCE Medifast, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Medifast Announces Winners of Mother-Daughter Challenge
2. Medifast, Inc. Announces Support for Microsoft HealthVault
3. Medifast Announces Updated Full Year 2007 Guidance
4. Medifast Announces Third-Quarter 2007 Results
5. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
6. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
7. Medifast, Inc. Director of Research & Development Co-Authors Health Book
8. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
9. DaVita Receives Civil Complaint
10. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
... research proves drug-coated stents effectively co...the real world.// A new study from researchers in...al trials of drug-coated stents represented a very...his new study takes a closer look at the effects o...
...ew study shows providing behavior and development ...ves the quality of pediatric health care and paren...ns Bloomberg School of Public Health followed near...s designed to bridge the gap between families and ...
...ew study shows that the risk of depression increas...own individuals who are insulin-resistant may have... prone to depression and even suicide. Research...y associated with depression and that their result...
...ew study reveals that a tonsillectomy procedure us...ay be the key to reducing pain during recovery. //...method, a special scalpel heats tissue as it goes ...procedure. The microdissection needle technique us...
Other Medicine News:Health News:Stronger Backing for Drug-Coated Stents 2
(Date:10/6/2008)...yphenol-rich 100% Concord grape,juice was not asso...body,weight, CONCORD, Mass., Oct. 6 /PRNewswire/ ...cord grape juice did not cause significant weight ...and was shown to reduce waist,circumference accord...ng of,the American College of Nutrition in Arlingt...
(Date:10/3/2008)...west study site, PHILADELPHIA, Oct. 3 /PRNewswire...lphia today received a contract to manage a new st...n,s Hospital will manage local,participation, recr...New,Jersey. The study is funded by the National In...roximately 1,000 families in Burlington,County wil...
(Date:10/3/2008)...FirstCall/ -- deCODE genetics,(Nasdaq: DCGN ) tod...drug,(IND) application for DG071, the company,s no...4 (PDE4), with the US Food and Drug Administration...nd potentially safer means,of targeting PDE4 to co...,with Alzheimer,s disease and other disorders in w...
(Date:10/2/2008)...ess and expanded reimbursement ...wire-FirstCall/ -- Uroplasty, Inc. (Amex:,UPI) ann...in a new,randomized, controlled multicenter clinic...ion system for the treatment of overactive bladder...nce and frequency of urinary,voids., The study is...
Breaking Medicine Technology:Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 3Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 4Digest This 3A Digestive Health Harder to Maintain Than Financial Health 15044 1Digest This 3A Digestive Health Harder to Maintain Than Financial Health 15044 2Digest This 3A Digestive Health Harder to Maintain Than Financial Health 15044 3U S EPA Approves Registration of Antimicrobial Copper Alloys 15042 1U S EPA Approves Registration of Antimicrobial Copper Alloys 15042 2High Performing Healthcare Organizations Have Seven Qualities in Common 15040 1High Performing Healthcare Organizations Have Seven Qualities in Common 15040 2High Performing Healthcare Organizations Have Seven Qualities in Common 15040 3Talent Shortage Emerges as No 1 Employer Concern 3A Deloitte ISCEBS 15038 1Talent Shortage Emerges as No 1 Employer Concern 3A Deloitte ISCEBS 15038 2Talent Shortage Emerges as No 1 Employer Concern 3A Deloitte ISCEBS 15038 3Talent Shortage Emerges as No 1 Employer Concern 3A Deloitte ISCEBS 15038 4
... Phase I Monthly Implant and Phase IIa Daily,Oral ...ewswire/ -- Debiopharm,Group (Debiopharm), a globa...list in oncology and serious medical conditions,p... ZT-1) studies,for the treatment of Alzheimer,s di...ional Conference on the Prevention of Dementia,in...
...un-2007 / Karo Bio (STO:KARO) successful,KB2115 Ph... proof,of concept phase II study with KB2115 in pa...pleted. KB2115 is efficacious in LDL,lowering and ...eflecting effects on heart, bone, muscle and thyro... a key regulator of,metabolic pathways and holds t...
Other Medicine Technology:Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease 2Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease 3Karo Bio Announces Sucessfule Phase II Results of KB2115 2Karo Bio Announces Sucessfule Phase II Results of KB2115 3
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: